id: NEW:proactive_arld_screening_to_NEW:early_liver_disease_detection
name: Proactive ARLD Screening in High-Risk Populations â†’ Early Liver Disease Detection
from_node:
  node_id: NEW:proactive_arld_screening
  node_name: Proactive ARLD Screening in High-Risk Populations
to_node:
  node_id: NEW:early_liver_disease_detection
  node_name: Early Liver Disease Detection
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: High-risk populations (people with alcohol use disorder or history of alcohol
  excess) are identified in key healthcare settings including inpatient addiction
  services, outpatient addiction services, general acute hospital admissions, and
  community outreach programs'
- 'Step 2: Proactive fibrosis assessment is conducted using screening tools to detect
  liver damage before clinical symptoms manifest'
- 'Step 3: Screening identifies significant proportions of patients with advanced
  liver disease (fibrosis and cirrhosis) who would otherwise remain undiagnosed'
- 'Step 4: Early detection enables intervention opportunities including reduced alcohol
  intake, hepatocellular carcinoma surveillance enrollment, and management of liver-related
  complications'
- 'Step 5: Earlier identification shifts diagnosis from late-stage presentation (with
  high mortality) to earlier stages with improved treatment potential'
evidence:
  quality_rating: B
  n_studies: 15
  primary_citation: 'Ann J Archer et al. 2024. Proactive case finding of alcohol-related
    liver disease in high-risk populations: A systematic review. Liver international:
    official journal of the International Association for the Study of the Liver.'
  supporting_citations: []
description: Systematic review of 15 studies demonstrates that proactive screening
  for alcohol-related liver disease among high-risk populations (those with AUD or
  alcohol excess history) successfully identifies fibrosis and cirrhosis at earlier
  stages. The yield of screening varies substantially by setting, with acute hospital
  admissions detecting cirrhosis in 10.8%-29.6% of screened individuals, compared
  to 1.2%-2.3% in community outreach. This targeted approach is feasible across multiple
  healthcare settings and identifies patients at risk of advanced liver disease who
  would otherwise present at late stages with poor prognosis.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: screening_setting
  direction: strengthens
  strength: strong
  description: Acute hospital admissions yield highest cirrhosis detection (10.8%-29.6%),
    while community outreach yields lowest (1.2%-2.3%). Inpatient AUD admissions show
    highest overall yield for case finding.
- name: patient_engagement_venue
  direction: strengthens
  strength: moderate
  description: 'Four key settings identified: inpatient addiction services, outpatient
    addiction services, general acute hospital admissions, and community outreach
    - each with different yields for detecting advanced liver disease'
